Adverse outcome of AML with aberrant CD16 and CD56 NK cell marker expression

Hematological Oncology, EarlyView.

Source: Hematological Oncology - June 4, 2018 Category: Hematology Authors: AlexandraJunge , UlrikeBacher , Beatrice U.Mueller , PeterKeller , MaxSolenthaler , ThomasPabst Source Type: research